Follow @CBHolman on Twitter
Congress passed – unanimously in the Senate and without debate – and President Obama will sign, H.R. 2019, the “Gabriella Miller Kids First Research Act” (named after a 10-year old child who died last year of brain cancer). If the legislation actually did what it touts – to finance pediatric research – it would be a noble bill for a noble cause.
But it is a fig-leaf bill. Its real purpose is to begin dismantling the presidential public financing system, and is very unlikely to produce any revenues for pediatric research.
The bill was originally introduced in the U.S. House of Representatives by U.S. Rep. Gregg Harper (R-Miss.), a longtime opponent of campaign finance reform. After Harper was unable to persuade Congress to approve earlier legislation that would have entirely defunded the public financing program, Harper re-worked the bill into what it is known now.
The legislation transfers public funds used to pay for the nominating conventions into the general treasury, then states that those funds may be used for pediatric research, if Congress ever decides to appropriate the funds for that purpose.
This same Congress slashed National Institute of Health (NIH) funding by $1.55 billion, which finances the pediatric research program, in the appropriations bills, and then placed caps on any further spending by NIH. The Kids First Research Act, if ever implemented, would transfer from the presidential public financing system to pediatric research, a pittance of what Congress slashed from the research budget. And even that pittance is not likely to happen. Given current spending caps on governmental agencies, Congress also would have to pass legislation lifting the spending ceiling for the National Institutes of Health to carry through with this appropriation, something that this Congress is very unlikely to do.